Diseases Covered

Myeloproliferative Diseases

Includes: Hypereosinophilic Syndrome, Myelofibrosis, Essential Thrombocytosis, Polycythemia vera

All pictures shown are used for illustrative purposes only.

Program Status

open

Apply Now

We encourage you to apply for assistance; see the qualifications below.

Assistance Amount

$ 6,500

Ask your Good Days Patient Care Navigator for more information.

Eligibility Criteria

Patient must be diagnosed with a covered disease and program must be accepting enrollments
Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
Patient is required to have valid Medicare or Military insurance coverage
Patient income level must be at or below 500% of the Federal Poverty Level (FPL)

Apply Now

Medications Covered
Disease Description

Agrylin
Anagrelide
Droxia/Hydrea
Gleevec
Hydrea
Hydroxyurea
Imatinib Mesylate
Inrebic
Jakafi

Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells. (Source: NIH; National Cancer Institute)

Medications Covered

Agrylin
Anagrelide
Droxia/Hydrea
Gleevec
Hydrea
Hydroxyurea
Imatinib Mesylate
Inrebic
Jakafi

Disease Description

Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells. (Source: NIH; National Cancer Institute)

Myeloproliferative Diseases

Program Status

open

Assistance Amount

$ 6,500

Eligibility Criteria

Medications Covered

Disease Description

Medications Covered

Disease Description

Apply For Assistance

Get Our Newsletter

Helpful Links